• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prediction of Recurrence by Machine Learning in Salivary Gland Cancer Patients After Adjuvant (Chemo)Radiotherapy.机器学习预测涎腺癌患者辅助(放)化疗后复发
In Vivo. 2021 Nov-Dec;35(6):3355-3360. doi: 10.21873/invivo.12633.
2
Salivary gland carcinoma (SGC) with perineural spread and/or positive resection margin - high locoregional control rates after photon (chemo) radiotherapy - experience from a monocentric analysis.唾液腺癌(SGC)伴神经周围侵犯和/或切缘阳性 - 光子(放化疗)后高局部区域控制率 - 单中心分析经验。
Radiat Oncol. 2019 Apr 23;14(1):68. doi: 10.1186/s13014-019-1260-x.
3
Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas.辅助放疗与同步放化疗治疗高危涎腺癌的疗效比较
Head Neck. 2016 Nov;38(11):1628-1633. doi: 10.1002/hed.24484. Epub 2016 Apr 21.
4
Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.辅助调强放疗联合或不联合同期化疗治疗唾液腺肿瘤。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):308-14. doi: 10.1016/j.ijrobp.2010.09.042. Epub 2010 Nov 13.
5
Adjuvant Chemotherapy Is Associated With Improved Survival for Late-Stage Salivary Squamous Cell Carcinoma.辅助化疗与晚期涎腺鳞状细胞癌的生存率提高相关。
Laryngoscope. 2019 Apr;129(4):883-889. doi: 10.1002/lary.27444. Epub 2018 Aug 27.
6
Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies.同步放化疗在高危原发性涎腺恶性肿瘤辅助治疗中的应用
Am J Clin Oncol. 2018 Sep;41(9):888-893. doi: 10.1097/COC.0000000000000386.
7
Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.新辅助(放化疗)后残余侧方淋巴结转移对局部进展期低位直肠癌患者预后的影响。
BJS Open. 2019 Jul 25;3(6):822-829. doi: 10.1002/bjs5.50194. eCollection 2019 Dec.
8
Decision tree algorithm in locally advanced rectal cancer: an example of over-interpretation and misuse of a machine learning approach.决策树算法在局部进展期直肠癌中的应用:机器学习方法过度解读和误用的一个实例。
J Cancer Res Clin Oncol. 2020 Mar;146(3):761-765. doi: 10.1007/s00432-019-03102-y. Epub 2019 Nov 29.
9
Effect of Chemoradiotherapy on the Survival of Resectable Gastric Cancer Patients: A Systematic Review and Meta-Analysis.放化疗对可切除胃癌患者生存的影响:一项系统评价和Meta分析
Ann Surg Oncol. 2022 Oct;29(11):6962-6975. doi: 10.1245/s10434-022-12005-1. Epub 2022 Jun 20.
10
Adjuvant Therapy for Salivary Gland Carcinomas.唾液腺癌的辅助治疗
Anticancer Res. 2016 Aug;36(8):4165-70.

引用本文的文献

1
Current Developments in Diagnosis of Salivary Gland Tumors: From Structure to Artificial Intelligence.唾液腺肿瘤诊断的当前进展:从结构到人工智能
Life (Basel). 2024 Jun 5;14(6):727. doi: 10.3390/life14060727.
2
Artificial Intelligence in the Diagnosis of Oral Diseases: Applications and Pitfalls.人工智能在口腔疾病诊断中的应用与陷阱
Diagnostics (Basel). 2022 Apr 19;12(5):1029. doi: 10.3390/diagnostics12051029.

本文引用的文献

1
Primary squamous cell carcinoma of major salivary gland: "Sapienza Head and Neck Unit" clinical recommendations.大唾液腺原发性鳞状细胞癌:“萨皮恩扎头颈科”临床建议
Rare Tumors. 2020 Nov 24;12:2036361320973526. doi: 10.1177/2036361320973526. eCollection 2020.
2
Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.涎腺黏液表皮样癌:法国罕见头颈部肿瘤网络(REFCOR)的 292 例前瞻性研究。
Eur J Surg Oncol. 2021 Jun;47(6):1376-1383. doi: 10.1016/j.ejso.2020.11.123. Epub 2020 Nov 21.
3
Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers.机器学习算法在(放化疗)治疗结果预测中的应用:分类器的实证比较。
Med Phys. 2018 Jul;45(7):3449-3459. doi: 10.1002/mp.12967. Epub 2018 Jun 13.
4
Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations.唾液腺癌的治疗管理:罗马“萨皮恩扎”大学乌姆伯托一世综合医院头颈部肿瘤治疗组的临床推荐。
Crit Rev Oncol Hematol. 2017 Dec;120:93-97. doi: 10.1016/j.critrevonc.2017.10.010. Epub 2017 Oct 27.
5
Follow-up program in head and neck cancer.头颈部癌症随访项目。
Crit Rev Oncol Hematol. 2017 May;113:151-155. doi: 10.1016/j.critrevonc.2017.03.012. Epub 2017 Mar 14.
6
Nomograms for predicting long-term overall survival and cancer-specific survival in patients with major salivary gland cancer: a population-based study.预测大唾液腺癌患者长期总生存和癌症特异性生存的列线图:一项基于人群的研究
Oncotarget. 2017 Apr 11;8(15):24469-24482. doi: 10.18632/oncotarget.14905.
7
Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual.头颈部肿瘤—美国癌症联合委员会第八版癌症分期手册的重大变化。
CA Cancer J Clin. 2017 Mar;67(2):122-137. doi: 10.3322/caac.21389. Epub 2017 Jan 27.
8
Outcomes after primary or adjuvant radiotherapy for salivary gland carcinoma.唾液腺癌原发性或辅助性放疗后的结局。
Acta Oncol. 2017 Mar;56(3):484-489. doi: 10.1080/0284186X.2016.1253863. Epub 2016 Nov 16.
9
Multidisciplinary Management of Salivary Gland Cancers.唾液腺癌的多学科管理
Cancer Control. 2016 Jul;23(3):242-8. doi: 10.1177/107327481602300307.
10
Machine learning applications in cancer prognosis and prediction.机器学习在癌症预后和预测中的应用。
Comput Struct Biotechnol J. 2014 Nov 15;13:8-17. doi: 10.1016/j.csbj.2014.11.005. eCollection 2015.

机器学习预测涎腺癌患者辅助(放)化疗后复发

Prediction of Recurrence by Machine Learning in Salivary Gland Cancer Patients After Adjuvant (Chemo)Radiotherapy.

机构信息

Department of Radiotherapy, Policlinico Umberto I "Sapienza" University of Rome, Rome, Italy;

Department of Oral and Maxillo Facial Sciences, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.

出版信息

In Vivo. 2021 Nov-Dec;35(6):3355-3360. doi: 10.21873/invivo.12633.

DOI:10.21873/invivo.12633
PMID:34697169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8627718/
Abstract

BACKGROUND/AIM: To investigate survival outcomes and recurrence patterns using machine learning in patients with salivary gland malignant tumor (SGMT) undergoing adjuvant chemoradiotherapy (CRT).

PATIENTS AND METHODS

Consecutive SGMT patients were identified, and a data set included nine predictor variables and a dependent variable [disease-free survival (DFS) event] was standardized. The open-source R software was used. Survival outcomes were estimated by the Kaplan-Meier method. The random forest approach was used to select the important explanatory variables. A classification tree that optimally partitioned SGMT patients with different DFS rates was built.

RESULTS

In total, 54 SGMT patients were included in the final analysis. Five-year DFS was 62.1%. The top two important variables identified were pathologic node (pN) and pathologic tumor (pT). Based on these explanatory variables, patients were partitioned in three groups, including pN0, pT1-2 pN+ and pT3-4 pN+ with 26%, 38% and 75% probability of recurrence, respectively. Accordingly, 5-year DFS rates were 73.7%, 57.1% and 34.3%, respectively.

CONCLUSION

The proposed decision tree algorithm is an appropriate tool to partition SGMT patients. It can guide decision-making and future research in the SGMT field.

摘要

背景/目的:利用机器学习研究接受辅助放化疗(CRT)的涎腺癌(SGMT)患者的生存结果和复发模式。

方法

连续纳入 SGMT 患者,建立一个包含九个预测变量和一个因变量(无病生存(DFS)事件)的数据集并进行标准化。使用开源 R 软件。采用 Kaplan-Meier 法估计生存结果。采用随机森林法选择重要的解释变量。构建一个分类树,以最优方式划分具有不同 DFS 率的 SGMT 患者。

结果

共纳入 54 例 SGMT 患者进行最终分析。5 年 DFS 率为 62.1%。确定的前两个重要变量是病理淋巴结(pN)和病理肿瘤(pT)。基于这些解释变量,患者被分为三组,包括 pN0、pT1-2 pN+和 pT3-4 pN+,复发概率分别为 26%、38%和 75%。相应地,5 年 DFS 率分别为 73.7%、57.1%和 34.3%。

结论

提出的决策树算法是一种划分 SGMT 患者的合适工具。它可以为 SGMT 领域的决策和未来研究提供指导。